Home » ONCOLYTICS BIOTECH INC. ANNOUNCES ISSUANCE OF SECOND CANADIAN PATENT
ONCOLYTICS BIOTECH INC. ANNOUNCES ISSUANCE OF SECOND CANADIAN PATENT
October 7, 2005
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") announced today it has been granted Canadian Patent 2,428,206 entitled "Methods for the treatment of cellular proliferative disorders." The claims describe methods of treating various types of cellular proliferative disorders including neurofibromatosis and neoplasms (cancers) by the administration of various strains of the reovirus.
Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/October2005/07/c8728.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct